-
First-In-Human Transdermal Continuous Cardiac Biomarker Monitoring Showcased at the ACC.24
Highlights from a First-In-Human transdermal continuous monitoring reveal real-time biomarker trends from RCE’s wrist wearable
-
Peer-reviewed translational research for an optical based transdermal sensor
-
RCE secures its milestone patent
Feburary 22, 2022 | Carlsbad, CA RCE, the AI med tech company developing point of care Troponin diagnostics, has announced the award of its first patent from the U. S. Patent and Trademark Office (USPTO). The patent details an optical based technique for the transdermal measurement of cardiac biomarkers. Diagnostic biomarkers are vital in determining…
-
Fostering Creativity, Not Stifling It.
Feb 19, 2022 | Atandra Burman Creativity is the act of conceiving something new, while Innovation is the act of putting that something new in practice. In other words, innovation is a direct manifestation of creative thinking. Creative thinking skills involve looking at a problem from different and creative angles, using the right tools to…
-
Value of Troponin in the absence of ischemic symptoms and ECG in non-cardiac surgeries
With over 300 million non-cardiac surgeries worldwide each year, more than 10 million patients develop major cardiac complications in the “perioperative” period. ie. within 30 days after non-cardiac surgeries. Perioperative cardiac complications can manifest as heart attacks, better referered to as perioperative myocardial infarctions (PMI). PMIs can be caused due to unstable coronary plaques (type…
-
False positive and false negative measurements with Troponin
Various cases in the hospitalization of patients with elevated Troponins have revealed certain false positives and false negatives with current lab assays in the measurement of cardiac Troponins, a biomarker specific to myocardial injury. It is prudent to raise awareness in the understanding, investigation and management of such scenarios in the best interest of patient…
-
Introducing the TMCx Fall 2020 cohort
RCE is 1 of 7 companies selected from around the world into TMCx Fall 2020 cohort. RCE is 1 of 7 companies selected from around the world into TMCx Fall 2020 cohort. With over 300 life science startups launched and $4.71B raised to date, TMC Innovation is at the forefront of advancing life sciences with…
-
GaBio Summit Winners 2020
Georgia Bio announces RCE as the winner of its 2020 GaBio Summit Pitch Rounds competition. Today, Georgia Bio announced RCE as the winner of its 2020 GaBio Summit Pitch Rounds competition.
-
Rule-out, or not, that is the heart of the question
A personal experience, and the could have been value of high sensitivity troponin in outcomes. Oct 29, 2020 | Jitto Titus It was just another day in Chennai, India, driving through the sea of vehicles when suddenly he felt some discomfort in his chest. As beads of sweat dripped down his brow, he clutched the…
-
Detecting Ischemia via the RCE wearable
RCE’s AI team trained a convolutional neural net on retrospective ECG data sets with ischemic vs non-ischemic classification. We then applied the held out model to prospective datasets from patients in cardiac observation unit. The accuracy of the model coupled with reliable data acquisition through a seamless ECG wearable is highly encouraging. These initial efforts…